Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective
The Clinical Respiratory Journal · 2026-11 · 20 (11)
DOI: 10.1111/crj.70236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 03.11.2026. Verfasst von Qinyu Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Pulmonary Emphysema. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission, Physician-scientist project of Shanghai Jiao Tong University School of Medicine, Student Innovation Training Program of Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Background Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome defined by the coexistence of upper‐lobe emphysema and lower‐lobe pulmonary fibrosis. It is characterized by clinical, functional, and radiologic features that differ significantly from isolated idiopathic pulmonary fibrosis or chronic obstructive pulmonary disease. Summary This review summarizes recent advances in CPFE, focusing on etiologic classification, clinical and radiologic features, diagnosis and treatment, prognostic evaluation, and emerging perspectives in artificial intelligence (AI). Based on current research, we summarize the etiologic classification of CPFE into four types: smoking‐related, systemic autoimmune rheumatic disease‐associated, occupational‐ and environmental‐related, and idiopathic. These types differ in epidemiologic characteristics, imaging patterns, and disease progression. Consequently, future research is expected to focus on mechanism‐driven phenotyping and quantitative imaging analysis, where AI may provide additional value in disease identification, risk stratification, and dynamic prognostic assessment. Key Message This review proposes a novel framework for CPFE, integrating etiologic subtyping and a diagnostic algorithm to guide precise management, and highlights AI‐powered strategies for future personalized interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
- School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
- Department of Pulmonary and Critical Care Medicine, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
ORCID-Profile: Qinyu Deng, Jianqi Sun, Feng Li
Förderung
- Shanghai Municipal Health Commission
- Physician-scientist project of Shanghai Jiao Tong University School of Medicine
- Student Innovation Training Program of Shanghai Jiao Tong University School of Medicine
- Shanghai Municipal Medical Outstanding Young Medical Talent Training Program
- Shanghai Jiao Tong University Cultivation Platform for Future Cross-Disciplinary Innovative Talents
Zitieren
APA
Deng, Q., Chen, C., Zhang, Q., Wei, Z., Sun, J., & Li, F. (2026). Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective. The Clinical Respiratory Journal, 20(11). https://doi.org/10.1111/crj.70236
Vancouver
Deng Q, Chen C, Zhang Q, Wei Z, Sun J, Li F. Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective. The Clinical Respiratory Journal. 2026;20(11). doi:10.1111/crj.70236
BibTeX
@article{Deng2026,
author = {Deng, Qinyu and Chen, Chen and Zhang, Qinghe and Wei, Zilin and Sun, Jianqi and Li, Feng},
title = {Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective},
journal = {The Clinical Respiratory Journal},
year = {2026},
volume = {20},
number = {11},
doi = {10.1111/crj.70236}
}
EUVIMED